These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19301292)

  • 1. The roles of natriuretic peptides in pericardial fluid in patients with heart failure.
    Watanabe M; Kawaguchi S; Nakahara H; Hachimaru T
    Clin Cardiol; 2009 Mar; 32(3):159-63. PubMed ID: 19301292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction.
    Tanaka T; Hasegawa K; Fujita M; Tamaki SI; Yamazato A; Kihara Y; Nohara R; Sasayama S
    J Am Coll Cardiol; 1998 Feb; 31(2):399-403. PubMed ID: 9462585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction.
    Klemola R; Tikkanen I; Vuolteenaho O; Toivonen L; Laine M
    Eur J Heart Fail; 2001 Jan; 3(1):21-6. PubMed ID: 11163731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease.
    Nishikimi T; Shibasaki I; Iida H; Asakawa H; Matsushita Y; Mori H; Mochizuki Y; Okamura Y; Horinaka S; Kangawa K; Shimada K; Matsuoka H
    Clin Sci (Lond); 2002 Jun; 102(6):669-77. PubMed ID: 12049623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
    Sagnella GA
    Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
    Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
    Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies.
    Zhu BL; Ishikawa T; Michiue T; Li DR; Zhao D; Tanaka S; Kamikodai Y; Tsuda K; Okazaki S; Maeda H
    Int J Legal Med; 2007 Jan; 121(1):28-35. PubMed ID: 16741745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1411-6. PubMed ID: 14666013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D; Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.